It has been reported that HIF-1α preferentially induces genes in the glycolytic pathway and HIF-2α is involved in the regulation of genes important for tumor growth, cell cycle progression and maintaining stem cell pluripotency, including c-Myc and the stem cell factor OCT-3/4 [35–38]. This evidence concerns the gene EPAS1 and neoplasm.